RARECommon stockNASDAQ
RARE Common stock
This is the ticker-level security page. The issuer is Ultragenyx Pharmaceutical Inc..
Security details
Issuer financial context
These figures belong to the issuer company, not to this security itself.
Revenue TTM
$630.6M
Net income TTM
-$579.8M
Total assets
$1.2B
Total debt
Not available
Total equity
$9.2M
Profit margin
Not available
ROE
Not available
ROA
-48.7%
Latest issuer financial snapshot: 2024-12-31